DEEP BRAIN STIMULATION DEVICES MARKET OVERVIEW

The global deep brain stimulation devices market was valued at $881.9 million in 2018, and is projected to reach $2,802.6 million by 2026, registering a CAGR of 15.5%. 

Deep brain stimulation is defined as a surgery that involves the implantation of an electrical device in the body. This device is responsible for sending electrical signals to the areas of the brain, which are responsible for body movement. Furthermore, the devices which are used to monitor the stimulation of the brain are called deep brain stimulation devices. These devices are used in the treatment of various neurological disorders such as Parkinson's disease, epilepsy, essential tremor, dystonia, obsessive compulsive disorder, and others. In addition, deep brain stimulation devices are also used to block pain signals by sending an electrical impulse near the spine region.

Rise in prevalence of lifestyle diseases such as depression and chronic pain, increase in the number of neurological disorders, and investment for neurological R&D are the factors that drive the growth of the global deep brain stimulation devices market. Moreover, rise in demand for minimally invasive surgery, adoption of technologically advanced products, and surge in aging population also propels the deep brain stimulation devices market growth as they are more susceptible to neurological disorders such as Epilepsy, Parkinson’s disease, Alzheimer’s disease, and chronic pain. The major barriers for the growth of the deep brain stimulation devices market include side effects such as allergic reaction and tingling or prickling of the skin due to implantation of deep brain stimulation devices into the body and increase in device cost. However, the availability of other treatment options such as drug therapies and surgeries restrict the growth of the deep brain stimulation devices market.

KEY SEGMENTATIONS

The deep brain stimulation devices market is classified on the basis of application, end user, and region. Based on application, the market is classified into Parkinson's disease, epilepsy, essential tremor, dystonia, obsessive compulsive disorder, and others. On the basis of end user, the market is categorized into hospitals, ambulatory surgical centers, neurological clinics, and others. Region wise, the deep brain stimulation devices market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

APPLICATION SEGMENT REVIEW

On the basis of application, the Parkinson’s disease segment acquired the major share of the market in 2018 and is expected to maintain this lead during the forecast period. Furthermore, the segment is also expected to exhibit the fastest growth rate during the forecast period, owing to surge in prevalence of Parkinson worldwide. In addition, surge in awareness toward the treatment options available for the disease also fuels the growth of the deep brain stimulation devices market.

END USER SEGMENT REVIEW

According to end users, the hospital segment accounted for the highest deep brain stimulation devices market share in 2018. In addition, the segment is also expected to exhibit the fastest growth rate during the forecast period, owing to rise in the number of hospitals worldwide. Furthermore, neurological disorders are diagnosed and treated by the use of advanced equipment used by a professional neurologist, who are available in specialty hospitals. Thus, this leads to surge in growth of the hospital segment in the deep brain stimulation devices market.

In 2018, North America accounted for the major share of the deep brain stimulation devices market size and is expected to continue this trend, owing to higher number of R&D activities, presence of skilled technicians, and wide availability of technologically advanced deep brain stimulation devices. Moreover, surge in prevalence of various neurological disorders is another factor that boost the deep brain stimulation devices market in the region. On the other hand, Asia-Pacific is estimated to register the fastest growth during the forecast period, owing to rise in healthcare expenditure and surge in prevalence of various neurological disorders such as epilepsy and others.

The global deep brain stimulation devices market is highly competitive and the prominent players in the market have adopted various strategies for garnering maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corporation, Functional Neuromodulation Ltd., Beijing PINS Medical Co., Ltd., Medtronic plc, NeuroPace Inc., Nevro Corporation, and Neuronetics Inc.

KEY BENEFITS FOR STAKEHOLDERS

• This report entails a detailed quantitative analysis along with the current global deep brain stimulation devices market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The deep brain stimulation devices market forecast is studied from 2019 to 2026.
• The deep brain stimulation devices market size and estimations are based on a comprehensive analysis of key developments in the deep brain stimulation devices industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

KEY MARKET SEGMENTS

By Application

• Parkinson's Disease
• Epilepsy
• Essential Tremor
• Dystonia
• Obsessive Compulsive Disorder
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Neurological Clinics
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Top investment pockets

3.3. Key forces shaping deep brain monitoring industry/market

3.4. Drivers

3.4.1. Increase in prevalence of neurological disorders

3.4.2. Surge in neurological R&D

3.4.3. Restraints

3.4.3.1. Risks and side effects associated with deep brain stimulation

3.4.4. Opportunities

3.4.4.1. Alternative uses of deep brain stimulators

3.4.5. Impact Analyses

CHAPTER 4: DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Parkinson's Disease

4.2.1. Market size and forecast, by region

4.2.2. Market analysis, by country

4.3. Epilepsy

4.3.1. Market size and forecast, by region

4.3.2. Market analysis, by country

4.4. Dystonia

4.4.1. Market size and forecast, by region

4.4.2. Market analysis, by country

4.5. Essential Tremor

4.5.1. Market size and forecast, by region

4.5.2. Market analysis, by country

4.6. Obsessive-compulsive Disorder

4.6.1. Market size and forecast, by region

4.6.2. Market analysis, by country

4.7. Others

4.7.1. Market size and forecast, by region

4.7.2. Market analysis, by country

CHAPTER 5: DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY END USER

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Market size and forecast, by region

5.2.2. Market analysis, by country

5.3. Ambulatory Surgical Centers

5.3.1. Market size and forecast, by region

5.3.2. Market analysis, by country

5.4. Neurological Clinics

5.4.1. Market size and forecast, by region

5.4.2. Market analysis, by country

5.5. Others

5.5.1. Market size and forecast, by region

5.5.2. Market analysis, by country

CHAPTER 6: DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities

6.2.2. Market size and forecast, by application

6.2.3. Market size and forecast, by end user

6.2.4. Market size and forecast, by country

6.2.4.1. U.S. market size and forecast, by application

6.2.4.2. U.S. market size and forecast, by end user

6.2.4.3. Canada market size and forecast, by application

6.2.4.4. Canada market size and forecast, by end user

6.2.4.5. Mexico market size and forecast, by application

6.2.4.6. Mexico market size and forecast, by end user

6.3. Europe

6.3.1. Key market trends and opportunities

6.3.2. Market size and forecast, by application

6.3.3. Market size and forecast, by end user

6.3.4. Market size and forecast, by country

6.3.4.1. Germany market size and forecast, by application

6.3.4.2. Germany market size and forecast, by end user

6.3.4.3. France market size and forecast, by application

6.3.4.4. France market size and forecast, by end user

6.3.4.5. UK market size and forecast, by application

6.3.4.6. UK market size and forecast, by end user

6.3.4.7. Italy market size and forecast, by application

6.3.4.8. Italy market size and forecast, by end user

6.3.4.10. Rest of Europe market size and forecast, by application

6.3.4.11. Rest of Europe market size and forecast, by end user

6.4. Asia-Pacific

6.4.1. Key market trends and opportunities

6.4.2. Market size and forecast, by application

6.4.3. Market size and forecast, by end user

6.4.4. Market size and forecast, by country

6.4.4.1. China market size and forecast, by application

6.4.4.2. China market size and forecast, by end user

6.4.4.3. Japan market size and forecast, by application

6.4.4.4. Japan market size and forecast, by end user

6.4.4.5. India market size and forecast, by application

6.4.4.6. India market size and forecast, by end user

6.4.4.7. Australia market size and forecast, by application

6.4.4.8. Australia market size and forecast, by end user

6.4.4.9. Rest of Asia-Pacific market size and forecast, by application

6.4.4.10. Rest of Asia-Pacific market size and forecast, by end user

6.5. LAMEA

6.5.1. Key market trends and opportunities

6.5.2. Market size and forecast, by application

6.5.3. Market size and forecast, by end user

6.5.4. Market size and forecast, by country

6.5.4.1. Brazil market size and forecast, by application

6.5.4.2. Brazil market size and forecast, by end user

6.5.4.3. Saudi market size and forecast, by application

6.5.4.4. Saudi Arabia market size and forecast, by end user

6.5.4.5. South Africa market size and forecast, by application

6.5.4.6. South Africa market size and forecast, by end user

6.5.4.7. Rest of LAMEA market size and forecast, by application

6.5.4.8. Rest of LAMEA market size and forecast, by end user

CHAPTER 7: COMPANY PROFILES

7.1. Abbott Laboratories

7.1.1. Company overview

7.1.2. Company snapshot

7.1.3. Operating business segments

7.1.4. Product portfolio

7.1.5. Business performance

7.1.6. Key strategic moves and developments

7.2. Aleva Neurotherapeutics SA

7.2.1. Company overview

7.2.2. Company snapshot

7.2.3. Operating business segments

7.2.4. Product portfolio

7.2.5. Key strategic moves and developments

7.3. Boston Scientific Corporation

7.3.1. Company overview

7.3.2. Company snapshot

7.3.3. Operating business segments

7.3.4. Product portfolio

7.3.5. Business performance

7.3.6. Key strategic moves and developments

7.4. Medtronic Plc

7.4.1. Company overview

7.4.2. Company snapshot

7.4.3. Operating business segments

7.4.4. Product portfolio

7.4.5. Business performance

7.5. NeuroPace Inc.

7.5.1. Company overview

7.5.2. Company snapshot

7.5.3. Operating business segments

7.5.4. Product portfolio

7.5.5. Key strategic moves and developments

7.6. Nevro Corporation

7.6.1. Company overview

7.6.2. Nevro: Company Snapshot

7.6.3. Operating business segment

7.6.4. Product portfolio

7.6.5. Business performance

7.6.6. Key strategic moves and developments

7.7. Neuronetics Inc.

7.7.1. Company overview

7.7.2. Neuronetics: Company Snapshot

7.7.3. Operating business segments

7.7.4. Product portfolio

7.7.5. Business performance

7.7.6. Key strategic moves and developments

7.8. Functional Neuromodulation Ltd

7.8.1. Company overview

7.8.2. Functional.: Company Snapshot

7.8.3. Operating business segments

7.8.4. Product portfolio

7.9. Beijing PINS Medical Co., Ltd

7.9.1. Company overview

7.9.2. Beijing.: Company Snapshot

7.9.3. Operating business segments

7.9.4. Product portfolio

LIST OF TABLES

TABLE 01. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 02. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR PARKINSON'S DISEASE, BY REGION, 2018–2026 ($MILLION)

TABLE 03. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR EPILEPSY, BY REGION, 2018–2026 ($MILLION)

TABLE 04. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR DYSTONIA, BY REGION, 2018–2026 ($MILLION)

TABLE 05. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR ESSENTIAL TREMOR, BY REGION, 2018–2026 ($MILLION)

TABLE 06. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OBSESSIVE COMPULSIVE DISORDER, BY REGION, 2018–2026 ($MILLION)

TABLE 07. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)

TABLE 08. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 09. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)

TABLE 10. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2026 ($MILLION)

TABLE 11. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR NEUROLOGICAL CLINICS, BY REGION, 2018–2026 ($MILLION)

TABLE 12. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)

TABLE 13. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY REGION, 2018-2026, ($MILLION)

TABLE 14. NORTH AMERICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 15. NORTH AMERICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 16. NORTH AMERICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)

TABLE 17. U.S. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 18. U.S. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 19. CANADA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 20. CANADA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 21. MEXICO DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 22. MEXICO DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 23. EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 24. EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 25. EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)

TABLE 26. GERMANY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 27. GERMANY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 28. FRANCE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 29. FRANCE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 30. UK DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 31. UK DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 32. ITALY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 33. ITALY DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 34. REST OF EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 35. REST OF EUROPE DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 36. ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 37. ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 38. ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)

TABLE 39. CHINA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 40. CHINA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 41. JAPAN DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 42. JAPAN DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 43. INDIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 44. INDIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 45. AUSTRALIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 46. AUSTRALIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 47. REST OF ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 48. REST OF ASIA-PACIFIC DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 49. LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 50. LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 51. LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)

TABLE 52. BRAZIL DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 53. BRAZIL DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 54. SAUDI ARABIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 55. SAUDI ARABIA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 56. SOUTH AFRICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 57. SOUTH AFRICA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 58. REST OF LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 59. REST OF LAMEA DEEP BRAIN STIMULATION MONITORING DEVICES MARKET BY END USER, 2018-2026, ($MILLION)

TABLE 60. ABBOTT: COMPANY SNAPSHOT

TABLE 61. ABBOTT: OPERATING SEGMENTS

TABLE 62. ABBOTT: PRODUCT PORTFOLIO

TABLE 63. ALEVA: COMPANY SNAPSHOT

TABLE 64. ALEVA: OPERATING SEGMENT

TABLE 65. ALEVA: PRODUCT PORTFOLIO

TABLE 66. BOSTON: COMPANY SNAPSHOT

TABLE 67. BOSTON: OPERATING SEGMENTS

TABLE 68. BOSTON: PRODUCT PORTFOLIO

TABLE 69. MEDTRONIC: COMPANY SNAPSHOT

TABLE 70. MEDTRONIC: OPERATING SEGMENTS

TABLE 71. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 72. NEUROPACE.: COMPANY SNAPSHOT

TABLE 73. NEUROPACE: OPERATING SEGMENTS

TABLE 74. NEUROPACE: PRODUCT PORTFOLIO

TABLE 75. NEVRO.: OPERATING SEGMENTS

TABLE 76. NEVRO.: PRODUCT PORTFOLIO

TABLE 77. NEURONETICS: OPERATING SEGMENT

TABLE 78. NEURONETICS: PRODUCT PORTFOLIO

TABLE 79. FUNCTIONAL.: OPERATING SEGMENT

TABLE 80. FUNCTIONAL.: PRODUCT PORTFOLIO

TABLE 81. BEIJING.: OPERATING SEGMENT

TABLE 82. BEIJING.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. DEEP BRAIN STIMULATION MONITORING DEVICES MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. MODERATE BARGAINING POWER OF SUPPLIER

FIGURE 04. MODERATE BARGAINING POWER OF BUYERS

FIGURE 05. LOW THREAT OF SUBSTITUTES

FIGURE 06. HIGH INTENSITY OF RIVALRY

FIGURE 07. LOW THREAT OF NEW ENTRANT

FIGURE 08. IMPACT ANALYSES, DEEP BRAIN MONITORING MARKET

FIGURE 09. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2018 & 2026 (%)

FIGURE 10. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR EPILEPSY, BY COUNTRY, 2018 & 2026 (%)

FIGURE 11. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR DYSTONIA, BY COUNTRY, 2018 & 2026 (%)

FIGURE 12. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR ESSENTIAL TREMOR, BY COUNTRY, 2018 & 2026 (%)

FIGURE 13. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OBSESSIVE COMPULSIVE DISORDER, BY COUNTRY, 2018 & 2026 (%)

FIGURE 14. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)

FIGURE 15. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET, FOR HOSPITALS BY COUNTRY, 2018 & 2026 (%)

FIGURE 16. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018 & 2026 (%)

FIGURE 17. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MONITORING DEVICES MARKET FOR NEUROLOGICAL CLINICS, BY COUNTRY, 2018 & 2026 (%)

FIGURE 18. COMPARATIVE ANALYSIS OF DEEP BRAIN STIMULATION MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)

FIGURE 19. ABBOTT: NET SALES, 2016–2018 ($MILLION)

FIGURE 20. ABBOTT: REVENUE SHARE BY SEGMENT, 2018(%)

FIGURE 21. ABBOTT: REVENUE SHARE BY REGION, 2018(%)

FIGURE 22. BOSTON: NET SALES, 2016–2018 ($MILLION)

FIGURE 23. BOSTON: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 24. BOSTON: REVENUE SHARE BY REGION, BY 2018%

FIGURE 25. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)

FIGURE 26. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 27. MEDTRONIC: REVENUE SHARE BY REGION, 2018(%)

FIGURE 28. NEVRO: NET SALES, 2016–2018 ($MILLION)

FIGURE 29. NEVRO: REVENUE SHARE BY REGION,2018 %

FIGURE 30. NEURONETICS: NET SALES, 2016–2018 ($MILLION)

FIGURE 31. NEURONETICS: REVENUE SHARE BY REGION, 2018(%)